1,003
Views
2
CrossRef citations to date
0
Altmetric
Research Article

How automatic notification of infectious disease specialists impacted the management of Staphylococcus aureus bacteremia in a community hospital setting

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 321-325 | Received 26 Jun 2018, Accepted 15 Oct 2018, Published online: 11 Dec 2018

References

  • Kaasch AJ, Barlow G, Edgeworth JD, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies. J Infect Internet]. 2014;68(3):242–251. Available from. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4136490&tool=pmcentrez&rendertype=abstract
  • Gotland N, Uhre ML, Mejer N, et al. Long-term mortality and causes of death associated with Staphylococcus aureus bacteremia. A matched cohort study. J Infect [Internet]. Elsevier Ltd; 2016;73(4):346–357.
  • Bassetti M, Peghin M, Trecarichi EM, et al. Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality. PLoS One. 2017;12(2):1–11.
  • Buehrle K, Pisano J, Han Z, et al. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review. AJIC Am J Infect Control Internet]. Elsevier Inc.; 2017;45(7):713–716.
  • Turner RB, Valcarlos E, Won R, et al. Impact of infectious diseases consultation on clinical outcomes of patients with staphylococcus aureus bacteremia in a community health system. Antimicrob Agents Chemother. 2016;60(10):5682–5687.
  • Bai AD, Showler A, Burry L, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60(10):1451–1461.
  • Vogel M, Schmitz RPH, Hagel S, et al. Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis. Jounal Infect. 2016;72:19–28.
  • Jenkins TC, Price CS, Sabel AL, et al. Impact of Routine Infectious Diseases Service Consultation on the Evaluation, Management, and Outcomes of Staphylococcus aureus Bacteremia Internet]. 2008;47(3):1000–1008. Available from. Clin Infect Dis. http://cid.oxfordjournals.org/lookup/doi/10.1086/589926.
  • Pragman AA, Kuskowski MA, Abraham JM, et al. Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes. Infect Dis Clin Pract. 2012;20(4):261–267.
  • Nagao M, Iinuma Y, Saito T, et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect Internet]. European Society of Clinical Infectious Diseases. 2010;16(12):1783–1788.
  • Honda H, Krauss MJ, Jones JC, et al. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010;123(7):631–637.
  • Martin L, Harris MT, Brooks A, et al. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study. Internet BMC Infect Dis. 2015;15568:4–9.
  • Paulsen J, Solligård E, Damås JK, et al. The impact of infectious disease specialist consultation for Staphylococcus aureus bloodstream infections: a systematic review. Open Forum Infect Dis Internet]. 2016;3(2):ofw048. Available from. http://www.ncbi.nlm.nih.gov/pubmed/27047985.
  • Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285–292.
  • Nagao M, Yamamoto M, Matsumura Y, et al. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis. Infection Internet]. Springer Berlin Heidelberg; 2016;(Oct 5):1–9. Available from. http://link.springer.com/10.1007/s15010-016-0946-3
  • López-Cortés LE, Gálvez-Acebal J, Bereciartua-Bastarrica E, et al. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57(9):1225–1233.
  • Meyer C, Pett E. Improving the management of Staphylococcus aureus bacteraemia, including MRSA. BMJ Qual Improv Reports. 2013;2(1):1–5.
  • Forsblom E, Ruotsalainen E, Ollgren J, et al. Telephone consultation cannot replace bedside infectious disease consultation in the management of staphylococcus aureus bacteremia. Clin Infect Dis. 2013;56(4):527–535.
  • BioMerieux. Vitek 2 data base [Internet]. [cited 2018 May 12]. Available from: http://www.biomerieux-diagnostics.com/vitekr-2-0
  • Viewics [Internet]. [cited 2018 May 12]. Available from: https://viewics.com/company/
  • Valour F, Karsenty J, Bouaziz A, et al. Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2014;58(2):746–755.
  • Vardakas KZ, Apiranthiti KN, Falagas ME. Antistaphylococcal penicillins versus cephalosporins for definitive treatment of meticillin-susceptible Staphylococcus aureus bacteraemia: A systematic review and meta-analysis. Int J Antimicrob Agents Internet]. Elsevier B.V.. 2014;44(6):486–492.